Major changes in lung cancer over the last ten years in France: The KBP-CPHG studies

Locher, C.; Debieuvre, D.; Coëtmeur, D.; Goupil, F.; Molinier, Olivier; Collon, Thierry; Dayen, C.; Treut, J. Le; Asselain, Bernard; Fortin, Martin; Blanchon, F; Grivaux, M

doi:10.1016/j.lungcan.2013.03.001

Cited by 103 publications

(34 citation statements)

References 28 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Finally, the study, whose strengths and limits have been previously discussed (8,32), confirms the poor 1-year survival in SCLC. It also confirms the impact of the cancer stage at diagnosis on survival rate and, in particular, the discrepancy between 1-year survival and management for stage IIIA and stage IIIB SCLCs, demonstrating the interest of the reintroduction of the TNM classification and the use of new diagnostic techniques, such as PET-scan, to offer more appropriate strategy for each patient.…”

Section: Discussionsupporting

confidence: 67%

“…A steering committee assessed study completeness by checking the regularity of inclusions throughout the year for all centres individually, and taken together, and the coherence of the data between 2000 and 2010 for centres which participated in both studies. Clinical research associates checked the completion of the questionnaires and contributed to the completeness of the recruitment (5,7,8).…”

Section: Methodsmentioning

confidence: 99%

“…The French College of General Hospital Respiratory Physicians (CPHG) has conducted two prospective multicentre epidemiological studies at a 10-year interval: KBP-2000-CPHG and KBP-2010-CPHG (5)(6)(7)(8)(9). These studies included all consecutive new cases of primary lung cancer histologically or cytologically proven in 2000 or 2010 and followed in the respiratory department of non-academic hospitals.…”

Section: Introductionmentioning

confidence: 99%

“…These studies included all consecutive new cases of primary lung cancer histologically or cytologically proven in 2000 or 2010 and followed in the respiratory department of non-academic hospitals. More than 900 of the 5,667 and 7,051 patients included in KBP-2000-CPHG and KBP-2010-CPHG cohorts had a SCLC (8). The large KBP-2010-CPHG cohorts allow descriptive statistics and outcome assessment for SCLC and NSCLC separately.…”

Section: Introductionmentioning

confidence: 99%

See 3 more Smart Citations

New insights into stage and prognosis in small cell lung cancer: an analysis of 968 cases

Dayen¹,

Debieuvre²,

Molinier³

et al. 2017

J. Thorac. Dis.

Self Cite

View full text Add to dashboard Cite

Background: The French College of General Hospital Respiratory Physicians conducted two studies that consecutively included all patients followed in participating general hospitals for primary small cell (SCLC) or non-small cell (NSCLC) lung cancer diagnosed in 2000 and 2010. These studies allow descriptive statistics and outcome assessment for SCLC and NSCLC separately and comparison over a 10-year period.Methods: A standardised form was completed for each patient at inclusion. Then, vital status was collected.

show abstract

Section: Discussionsupporting

confidence: 67%

Section: Methodsmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

New insights into stage and prognosis in small cell lung cancer: an analysis of 968 cases

Dayen¹,

Debieuvre²,

Molinier³

et al. 2017

J. Thorac. Dis.

Self Cite

View full text Add to dashboard Cite

show abstract

“…It was repeated in 2010 - by the same group - including more than 7,000 patients [4]. Their results have recently been published [5]. …”

Section: Introductionmentioning

confidence: 99%

Earlier Onset and Poor Prognosis of Lung Cancer in Imprisoned Patients

Carbonnaux

Fossard

Amzallag³

et al. 2013

Oncology

View full text Add to dashboard Cite

Introduction: Prison inmates are known to be more exposed to various lung cancer risk factors, and some studies have shown that lung cancer is the most common cancer in prisoners. However, no study has particularly focused on lung cancer features in this population. Method: Charts of patients with lung cancer hospitalized in one of the French secured hospital units between 1997 and 2012 were reviewed. Data from this cohort were then compared to those of two large observational studies conducted in 2000 and 2010 (KBP studies). Results: Thirty-two cases were included. All were men. The mean age was 52.2 ± 11.5 years, which was significantly lower than in the KBP-2000 (64.4 years) and KBP-2010 (65.5 years; both p < 0.0001) studies. The percentage of current smokers was much higher in prisoners (87.1 vs. 52.2 and 49.2%, respectively; both p < 0.001). Ninety percent of prisoners presented with at least one comorbidity. Lung cancer clinical presentation did not differ between prisoners and the reference populations. The median overall survival was 5.8 months (range 0-15.1) for all stages and 4.7 months (range 2.8-6.6) for stage IIIB/IV. Conclusion: Although our study suffers from limitations, prisoners seem to develop lung cancer at a younger age and their prognosis is poor.

show abstract

Prevalence of occupational exposure to asbestos and crystalline silica according to phenotypes of lung cancer from the CaProMat study: A case‐only study

Zoghbi

Salameh

Stücker

et al. 2017

American J Industrial Med

View full text Add to dashboard Cite

show abstract

Major changes in lung cancer over the last ten years in France: The KBP-CPHG studies

Cited by 103 publications

References 28 publications

New insights into stage and prognosis in small cell lung cancer: an analysis of 968 cases

New insights into stage and prognosis in small cell lung cancer: an analysis of 968 cases

Earlier Onset and Poor Prognosis of Lung Cancer in Imprisoned Patients

Prevalence of occupational exposure to asbestos and crystalline silica according to phenotypes of lung cancer from the CaProMat study: A case‐only study

Contact Info

Product

Resources

About